What is the price target for NEXI stock?
7 analysts have analysed NEXI and the average price target is 2.04 USD. This implies a price decrease of -48.09% is expected in the next year compared to the current price of 3.93.
NEXIMMUNE INC (NEXI) Forecast, Price Target & Analyst Ratings
NASDAQ:NEXI • US65344D2080
Current stock price
3.93 USD
+1.62 (+70.13%)
At close:
3.45 USD
-0.48 (-12.21%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEXIMMUNE INC (NEXI).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$2.04
Upside
-48.09%
From current price of $3.93 to mean target of $2.04, Based on 7 analyst forecasts
Low
$2.02
Median
$2.04
High
$2.10
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for NEXI. The average price target is 2.04 USD. This implies a price decrease of -48.09% is expected in the next year compared to the current price of 3.93.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
NEXI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NEXI.
In the previous month the buy percentage consensus was at a similar level.
NEXI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-16 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-11-15 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2022-08-16 | Barclays | Maintains | Overweight |
| 2022-08-16 | Raymond James | Maintains | Outperform |
| 2022-06-01 | BTIG | Initiate | Buy |
| 2022-02-22 | Raymond James | Maintains | Outperform |
| 2021-11-15 | Raymond James | Maintains | Outperform |
| 2021-04-01 | Raymond James | Initiate | Outperform |
| 2021-03-09 | Cantor Fitzgerald | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 7, 2024
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A 402.01% | N/A 165.52% | ||||||
| EBITDA YoY % growth | -13.04M | -20.45M -56.83% | -27.23M -33.15% | -52.38M -92.36% | -62.09M -18.54% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.24M | -20.89M -57.78% | -27.85M -33.32% | -53.25M -91.20% | -63.08M -18.46% | N/A 45.97% | N/A 14.39% | N/A 19.62% | N/A 5.00% | N/A 5.00% | N/A 10.90% | N/A 39.23% | N/A 119.67% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -19.15 | -66.25 -245.95% | N/A 99.01% | N/A 76.56% | N/A 40.00% | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.96%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
NEXIMMUNE INC / NEXI Forecast FAQ
What is the next earnings date for NEXI stock?
NEXIMMUNE INC (NEXI) will report earnings on 2024-08-07, after the market close.
How many analysts cover NEXIMMUNE INC (NEXI) stock?
The number of analysts covering NEXIMMUNE INC (NEXI) is 7.